Skip Navigation

Goldman Sachs says buy this biopharma stock that's poised to rally nearly 40% from here

Published Mon, Aug 8 20228:07 AM EDTUpdated Mon, Aug 8 20229:31 AM EDT

Samantha Subin @samantha_subin

More In Analyst Calls

Apple is about to jump into the AI race. Here's what analysts expect it to do

Apple is about to jump into the AI race. Here's what analysts expect it to do

This rare muscle disease play can rally more than 50%, BofA says

This rare muscle disease play can rally more than 50%, BofA says

Here are Friday's biggest analyst calls: Apple, Target, Coinbase, Berkshire Hathaway, Estee Lauder & more

Here are Friday's biggest analyst calls: Apple, Target, Coinbase, Berkshire Hathaway, Estee Lauder & more